LexDanaLexDanabeta
Inventor

SUSAN FAAS MCKNIGHT

Inventor
US

Overview

3→
Patents
2022–2024
Patent span
Human necessities
Primary field (CPC A)

Patents· 3 as inventor

Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.

A61Kprimary
A61KPreparations for medical, dental or toiletry purposes20%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations20%
C07KPeptides20%
G01NInvestigating or analysing materials by determining their chemical or physical properties13%
A01KAnimal husbandry7%
C12QMeasuring or testing processes involving enzymes, nucleic acids or microorganisms7%
C12YEnzymes7%
Y02ATechnologies for adaptation to climate change7%
PatentTitleYear
12,025,621Atypical hemolytic uremic syndrome (AHUS) biomarker proteins202411,459,382Dosage and administration of anti-C5 antibodies for treatment of protein-losing enteropathy in patients202211,364,284Methods of treating myointimal proliferation2022

Career & activity timeline

Assembled from patent assignee/location history and declaration credentials.

2022–2024Patents assigned to ALEXION PHARMA INC (2)· patent assignee history
2022Patents assigned to INOZYME PHARMA INC (1)· patent assignee history
2022Patents assigned to UNIV MUENSTER WESTFAELISCHE WILHELMS (1)· patent assignee history
2022–2024Based in US· patent location history

Inventor activity

Assignee and location history derived from the patent record.

Assignees
AssigneePatentsSpan
ALEXION PHARMA INC22022–2024
INOZYME PHARMA INC12022
UNIV MUENSTER WESTFAELISCHE WILHELMS12022
Locations
LocationPatentsSpan
US32022–2024